Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Michele Fuller

Advertisement

Articles by Michele Fuller

From Blockbusters to Black Holes: Pharma Launch Strategy in the Age of Technology and AI

ByKarla Anderson, Partner, Guidehouse,Michele Fuller,Cavay Ip, Director, Guidehouse
August 5th 2025
Advertisement

Latest Updated Articles

  • From Blockbusters to Black Holes: Pharma Launch Strategy in the Age of Technology and AI
    From Blockbusters to Black Holes: Pharma Launch Strategy in the Age of Technology and AI

    August 5th 2025



Advertisement
Advertisement

Trending on PharmExec

1

Novo Reports Real-World Data Showing Weight Loss After Switch to Oral Semaglutide Pill

2

Roundup: Hengrui Pharma and Novo Enter Exclusive License Agreement for HRS-1596, AstraZeneca Enters Collaboartion with Summit Therapeutics

3

New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report

4

As Peptide Rulemaking Stalls, FDA Enforcement Moves Forward

5

Pharmaceutical Executive Daily: Peptide Ruling Stalls

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us